Ramsey, Scott D.; Clarke, Lauren D.; Roberts, Craig S.; … - In: PharmacoEconomics 26 (2008) 4, pp. 329-339
Objective: The CARDS trial, a multicentre, randomized, controlled trial, found that atorvastatin 10 mg/day for patients with type 2 diabetes mellitus and normal low-density lipoprotein (LDL)-cholesterol significantly reduced cardiovascular (CV) events, including stroke. We estimated the cost...